A sliding intravenous dose schedule for clonidine in hypertensive patients
- 1 July 1976
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 20 (1) , 31-35
- https://doi.org/10.1002/cpt197620131
Abstract
Cumulative doses of clonidine were administered intravenously to 8 hypertensive patients to a maximal dose of 100 μg or a blood pressure fall to normal. There was a reduction in mean arterial pressure of 35.6 mm Hg (p < 0.001), accompanied by a decrease in heart rate of 11.8 bpm (p < 0.001). There was also a significant linear relationship between the reduction in blood pressure and the intravenous log dose of clonidine with a 6.5-fold difference in Δ MAP/dose potency. There was no correlation between the baseline blood pressure and the slopes of dose-blood pressure response curves or the reduction in mean arterial pressure; the rate of the decline of the hypotensive effect of clonidine varied widely between patients and was not related to baseline blood pressure.This publication has 3 references indexed in Scilit:
- Mechanism of Hypotensive Action of 2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride (ST-155) in the CatJournal of Pharmaceutical Sciences, 1968
- The antihypertensive effects of an imidazoline compoundClinical Pharmacology & Therapeutics, 1967
- ber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit ImidazolinstrukturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1967